• 1. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 2. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 3. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 4. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 5. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119

Methyl 4-methyl-3-oxoheptanoate (CAS No. 855955-01-0): A Comprehensive Overview

Methyl 4-methyl-3-oxoheptanoate, identified by its Chemical Abstracts Service number CAS No. 855955-01-0, is a compound of significant interest in the field of organic chemistry and pharmaceutical research. This ester, with the molecular formula C₉H₁₄O₃, has garnered attention due to its structural properties and potential applications in various chemical syntheses. The compound's unique structure, featuring a β-keto ester moiety, makes it a valuable intermediate in the synthesis of more complex molecules, particularly in the development of bioactive compounds.

The Methyl 4-methyl-3-oxoheptanoate molecule consists of a heptanoic acid backbone with a methyl group at the fourth carbon and an oxygen double bond at the third carbon, forming an α,β-unsaturated carbonyl system. This feature is particularly useful in organic synthesis, as it allows for various reactions such as Michael additions, condensations, and reductions, which are pivotal in constructing more intricate molecular architectures. The presence of both a methyl group and a keto group introduces asymmetry, which can be exploited to achieve stereoselective syntheses—a crucial aspect in pharmaceutical development where enantiomeric purity often determines the efficacy and safety of a drug.

In recent years, there has been growing interest in the applications of Methyl 4-methyl-3-oxoheptanoate in the synthesis of bioactive molecules. Its structural framework is reminiscent of natural products and pharmacophores found in various therapeutic agents. For instance, derivatives of this compound have been explored as potential intermediates in the synthesis of nonsteroidal anti-inflammatory drugs (NSAIDs) and other therapeutic agents targeting inflammatory pathways. The β-keto ester functionality is particularly attractive because it can undergo enolization to form an enolate ion, which is a versatile nucleophile in many synthetic transformations.

One of the most notable applications of Methyl 4-methyl-3-oxoheptanoate is in the field of agrochemicals. The compound has been investigated as a precursor for synthesizing novel pesticides and herbicides. Its ability to participate in condensation reactions with various nucleophiles allows for the creation of heterocyclic compounds that exhibit biological activity against pests and weeds. These findings are particularly relevant given the increasing demand for environmentally friendly and sustainable agricultural practices. The development of new agrochemicals that are both effective and environmentally benign remains a priority in modern agriculture.

The pharmaceutical industry has also shown interest in Methyl 4-methyl-3-oxoheptanoate due to its potential as a building block for more complex drug molecules. Researchers have explored its use in synthesizing analogs of known drugs to improve their pharmacokinetic properties or to discover new therapeutic entities. The compound's ability to undergo various chemical transformations makes it a valuable tool in medicinal chemistry. For example, it can be used to construct cycloalkylated derivatives that may exhibit enhanced binding affinity to biological targets or improved metabolic stability.

Recent advances in synthetic methodologies have further enhanced the utility of Methyl 4-methyl-3-oxoheptanoate. The development of catalytic systems that facilitate asymmetric transformations has allowed for the efficient synthesis of enantiomerically pure derivatives of this compound. Such advancements are crucial for pharmaceutical applications where the stereochemistry of a molecule can significantly impact its biological activity. Catalytic asymmetric hydrogenation, for instance, has been employed to selectively reduce the double bond or keto group while maintaining high enantioselectivity.

The role of computational chemistry in designing synthetic routes for Methyl 4-methyl-3-oxoheptanoate cannot be overstated. Molecular modeling techniques have enabled researchers to predict reaction outcomes and optimize synthetic pathways with greater precision. These computational tools have been instrumental in identifying novel catalysts and reaction conditions that enhance yield and selectivity. By integrating experimental data with computational predictions, scientists can develop more efficient synthetic strategies that minimize waste and energy consumption—a critical consideration in sustainable chemistry.

In conclusion, Methyl 4-methyl-3-oxoheptanoate (CAS No. 855955-01-0) is a versatile compound with significant potential in both pharmaceutical and agrochemical research. Its unique structural features make it an excellent intermediate for constructing complex molecules with biological activity. Recent advancements in synthetic chemistry and computational methods have further expanded its utility, making it an indispensable tool for chemists working on drug discovery and sustainable agricultural practices.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)